These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 478639)

  • 1. Immunosuppression and isolation of rubella virus from human lymphocytes after vaccination with two rubella vaccines.
    Buimovici-Klein E; Cooper LZ
    Infect Immun; 1979 Jul; 25(1):352-6. PubMed ID: 478639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.
    Vesikari T; Buimovici-Klein E
    Infect Immun; 1975 Apr; 11(4):748-53. PubMed ID: 1120613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens and responses to rubella vaccination.
    Harcourt GC; Best JM; Banatvala JE; Kennedy LA
    J Hyg (Lond); 1979 Dec; 83(3):405-12. PubMed ID: 512353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of lymphocyte PHA-responsiveness after rubella vaccination with Cendehill and RA 27/3 strains.
    Vesikari T
    Scand J Infect Dis; 1980; 12(1):7-11. PubMed ID: 7367839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression and alterations of T-lymphocyte subpopulations after rubella vaccination.
    Arneborn P; Biberfeld G; Wasserman J
    Infect Immun; 1980 Jul; 29(1):36-41. PubMed ID: 6967455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.
    Pukhalsky AL; Shmarina GV; Bliacher MS; Fedorova IM; Toptygina AP; Fisenko JJ; Alioshkin VA
    Mediators Inflamm; 2003 Aug; 12(4):203-7. PubMed ID: 14514470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failed rubella immunization in adults: association with immunologic and virological abnormalities.
    Tingle AJ; Chantler JK; Kettyls GD; Larke RP; Schulzer M
    J Infect Dis; 1985 Feb; 151(2):330-6. PubMed ID: 3968452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immunity in experimental rubella infections.
    Cappel R
    Arch Virol; 1975; 47(4):375-9. PubMed ID: 1137503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin-2 receptor alpha and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees.
    Toyoda M; Ihara T; Nakano T; Ito M; Kamiya H
    Vaccine; 1999 Apr; 17(15-16):2051-8. PubMed ID: 10217606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees.
    O'Shea S; Best JM; Banatvala JE; Shepherd WM
    J Infect Dis; 1985 Jan; 151(1):89-98. PubMed ID: 3965597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocyte subpopulations defined by monoclonal antibodies and FC receptor binding in relation to immunosuppression in vaccine-induced rubella infection.
    Arneborn P; Biberfeld G; von Stedingk LV
    Acta Pathol Microbiol Immunol Scand C; 1982 Jun; 90(3):163-70. PubMed ID: 6214140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viremia in a recipient of HPV-77 Rubella virus vaccine.
    Wilkins J; Salvatore MA; Leedom JM; Portnoy B
    Calif Med; 1969 Mar; 110(3):224-7. PubMed ID: 5773481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Japanese rubella vaccine: comparative trials.
    Best JM; Banatvala JE; Bowen JM
    Br Med J; 1974 Jul; 3(5925):221-4. PubMed ID: 4602899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.
    Al-Nakib W; Best JM; Banatvala JE
    Lancet; 1975 Jan; 1(7900):182-5. PubMed ID: 47417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the lymphocyte in vitro response to rubella antigen and phytohemagglutinin by a whole blood method.
    Buimovici-Klein E; Vesikari T; Santangelo CF; Cooper LZ
    Arch Virol; 1976; 52(4):323-31. PubMed ID: 1016065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella-associated arthritis: rescue of rubella virus from peripheral blood lymphocytes two years postvaccination.
    Chantler JK; Ford DK; Tingle AJ
    Infect Immun; 1981 Jun; 32(3):1274-80. PubMed ID: 7019092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
    Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
    Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of rubella antibodies after vaccination: detection after experimental challenge.
    Banatvala JE; Best JM; O'Shea S; Dudgeon JA
    Rev Infect Dis; 1985; 7 Suppl 1():S86-90. PubMed ID: 4001741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.